Search

Legend Biotech Corp ADR

Closed

SectorHealthcare

17.57 0.11

Overview

Share price change

24h

Current

Min

17.18

Max

17.84

Key metrics

By Trading Economics

Income

88M

33M

Sales

82M

388M

EPS

0.09

Profit margin

8.568

Employees

3,200

EBITDA

92M

60M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+160.84% upside

Dividends

By Acuity

Next Earnings

11 lis 2026

Market Stats

By TradingEconomics

Market Cap

-393M

3.6B

Previous open

17.46

Previous close

17.57

News Sentiment

By Acuity

100%

0%

321 / 339 Ranking in Healthcare

Legend Biotech Corp ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

17 wrz 2026, 23:46 UTC

Legend Biotech Corp saw a modest increase in after-market trading, though it remains significantly below its 20-day moving average.

16 wrz 2026, 20:10 UTC

News

Legend Biotech Corp shares fell sharply today despite reporting second-quarter CARVYKTI sales of $657 million, marking the tenth consecutive session of declines.

15 wrz 2026, 22:02 UTC

Legend Biotech shares were roughly flat in after-market hours, remaining significantly below their 20-day moving average after nine consecutive lower sessions.

14 wrz 2026, 19:36 UTC

Shares of Legend Biotech Corp are lower today, continuing a broader trend. The stock remains significantly below its 20-day moving average.

11 wrz 2026, 23:26 UTC

Legend Biotech Corp shares are higher in after-market trading, reflecting notable gains since Friday's close amid speculation about Federal Reserve interest rate hikes.

9 wrz 2026, 20:07 UTC

Legend Biotech Corp shares are lower, continuing a trend of four consecutive daily declines. The stock remains below its 20-day moving average.

8 wrz 2026, 23:06 UTC

Shares of Legend Biotech Corp. are higher in after-market trading, recovering from a recent decline that saw three consecutive lower closes.

3 wrz 2026, 19:47 UTC

Shares of Legend Biotech Corp are lower today, despite earlier fluctuations that reached a session high. The stock remains above its 20-day moving average.

2 wrz 2026, 20:03 UTC

News

Legend Biotech shares are higher as management discusses CARVYKTI's commercial rollout and plans to expand manufacturing capabilities at the Morgan Stanley Global Healthcare Conference.

1 wrz 2026, 20:01 UTC

News

Legend Biotech will participate in the Morgan Stanley Global Healthcare Conference on September 15, 2026, as shares trade higher since Monday's close.

31 sie 2026, 22:16 UTC

Legend Biotech Corp shares are higher in after-market hours, reflecting a shift from recent higher daily closes amid broader market reactions to inflation comments from the Fed.

28 sie 2026, 20:07 UTC

Legend Biotech Corp shares are lower today, marking a fourth consecutive decline. Rising U.S. Treasury yields may be impacting investor sentiment.

27 sie 2026, 22:26 UTC

Legend Biotech Corp. shares are higher in after-market trading, gaining slightly since Thursday's close amid routine market fluctuations.

26 sie 2026, 23:11 UTC

Legend Biotech Corp shares are higher in after-market hours, reflecting the broader market's upward trend amid positive sentiment from major stocks.

25 sie 2026, 19:06 UTC

Shares of Legend Biotech Corp are higher today, remaining above their 20-day moving average amid positive market sentiment linked to falling oil prices.

24 sie 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, continuing a strong upward trend since Monday's close. The stock remains above its 20-day moving average.

21 sie 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, maintaining a position near the upper end of their one-month trading range.

20 sie 2026, 23:46 UTC

Legend Biotech Corp. shares are trading higher in after-market hours, diverging from broader market pressures amid rising crude oil prices and geopolitical tensions.

19 sie 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, showing notable strength and exceeding the 20-day moving average. No specific news was identified.

18 sie 2026, 20:03 UTC

Social Media

Legend Biotech Corp shares are higher today, buoyed by strong investor sentiment and analyst confidence in significant upside potential for the stock.

14 sie 2026, 19:36 UTC

Shares of Legend Biotech Corp are trading higher, though fluctuations have been routine during the session. The stock remains below its 20-day moving average.

13 sie 2026, 23:21 UTC

Legend Biotech Corp shares are higher in after-market hours, gaining traction following notable trading activity after Thursday's close. No specific news was identified.

12 sie 2026, 23:16 UTC

Legend Biotech Corp. shares are higher in after-market hours, reflecting positive market conditions amid a Consumer Price Index report that met forecasts.

11 sie 2026, 23:46 UTC

Shares of Legend Biotech Corp are higher in after-market hours, maintaining a position above the 20-day moving average amid stable trading conditions.

10 sie 2026, 23:06 UTC

Shares of Legend Biotech are higher in after-market trading, settling above Monday's close despite mixed market sentiment and geopolitical tensions.

7 sie 2026, 23:46 UTC

Shares of Legend Biotech Corp traded higher in after-market hours, amid a broader market context of a declining unemployment rate.

6 sie 2026, 20:06 UTC

Legend Biotech Corp shares are higher today, reflecting a shift from recent trends. No specific company news was identified to explain this movement.

4 sie 2026, 19:36 UTC

Legend Biotech Corp shares are higher today, recovering from an earlier low. Positive momentum persists despite a decline in U.S. core factory orders.

3 sie 2026, 22:01 UTC

Shares of Legend Biotech Corp are higher in after-market trading, reflecting gains since Monday's close amid broader market advances in tech and oil-sensitive sectors.

31 lip 2026, 23:56 UTC

Shares of Legend Biotech Corp. are higher in after-market trading, despite a slight decline earlier in the session and broader market weakness.

Peer Comparison

Price change

Legend Biotech Corp ADR Forecast

Price Target

By TipRanks

160.84% upside

12 Months Forecast

Average 45.856 USD  160.84%

High 74 USD

Low 24 USD

Based on 9 Wall Street analysts offering 12 month price targets forLegend Biotech Corp ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

5

Buy

4

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Legend Biotech Corp ADR

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation.